Oswald's
MAY 4, 2025
A Chance Encounter That Changed Everything When I was 21 years old, while shopping for food for my brothers dog, I saw the most adorable little white furball and decided to adopt him. As getting a pet was not in my immediate life-plan, I was ill-prepared and had a lot to learn. I purchased a couple of books on owning a dog and started to bond with my new puppy.
DiversifyRx
MAY 3, 2025
If youre like most pharmacy owners, you probably dipped your toe into the world of 503B pharmacy dispensing when compounded GLP-1s like semaglutide and tirzepatide started flying off the shelves. But here’s the thingif you stopped there, youre leaving a mountain of cash on the table. Dispensing sterile compounded prescriptions from 503B outsourcing facilities isnt just about weight loss meds.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 4, 2025
Global virus and public health experts gathered to assess the need for an enhanced response to the bird flu spreading among humans and animals.
STAT
MAY 3, 2025
When word broke this week that the Department of Health and Human Services was investing half-a-billion dollars on a National Institutes of Health project to develop a vaccine platform for pathogens that could trigger pandemics, a number of scientists who work in the field of vaccinology had decidedly mixed feelings. That HHS and NIH are going to continue to invest in efforts to make vaccines that could reduce the impact of future pandemics was good news, many thought.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Oswald's
MAY 4, 2025
Check out our May 2025 specials at Oswalds Pharmacy! From Mothers Day gifts and allergy relief to backyard lighting, fun games, and top-quality medical equipment, weve got everything to brighten your month. Shop in-store while supplies last! The post May 2025 Promotions appeared first on Oswalds Pharmacy.
Pharmacy Times
MAY 4, 2025
New trials reveal xanomeline and trospium effectively alleviate schizophrenia symptoms, offering a novel treatment option with minimal adverse effects.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MAY 3, 2025
CHICAGO — With thousands of abstracts presented at the American Association for Cancer Research annual meeting, it’s hard to keep up with all the latest advances and data. Like every meeting, this year’s conference was full of presentations and posters detailing new innovations in treating and preventing cancer or detecting it early.
The FDA Law Blog
MAY 4, 2025
By Larry K. Houck Drug Enforcement Administration (DEA) civil monetary settlements involving listed chemicals that do not include pseudoephedrine are rare. Even more scarce are DEA civil settlements with non-registrants. (By my count there have been only ten since 2000). When one comes along, it is worthwhile to sit up and take notice. On March 26th the U.S.
Pharmacy Times
MAY 3, 2025
Reductions of about 32% were observed during the study.
Pharma Marketing Network
MAY 4, 2025
In todays complex landscape, pharma market research isnt just about collecting dataits about transforming that data into actionable intelligence. As 2025 unfolds, the stakes for pharmaceutical companies continue to rise. Between rapid regulatory changes, evolving HCP behavior, and digitally empowered patients, marketers are under pressure to make faster, smarter decisions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Med Ed 101
MAY 4, 2025
The prescribing cascade occurs when a side effect of a medication is misinterpreted as a new medical condition, leading to the prescription of additional medicines that may be unnecessary and potentially harmful. In patients with dementia, this can be common due to polypharmacy and the complexity of managing cognitive and behavioral symptoms. Here are five […] The post Prescribing Cascade in Dementia Care – My Top 5 appeared first on Med Ed 101.
STAT
MAY 3, 2025
CHICAGO — In the first few weeks of President Trump’s second term, many leaders and top scientists in cancer research found themselves questioning if they could have communicated better to the public. After all, experts told STAT, maybe if people understood how intimately connected cancer research is to the advances in technology, drugs, and care that have led to a 34% reduction in the cancer mortality rate since 1991, perhaps the government wouldn’t have so dramatically cut
Pharmacy Times
MAY 3, 2025
New research highlights the need for evidence-based buspirone use in psychiatric settings, revealing high off-label prescriptions and suboptimal dosing practices.
Pharmacy Times
MAY 3, 2025
In chronic hepatitis B (CHB) mouse models, the ferritin nanoparticle-preS1 (ferritin-NP-preS1) with small interfering RNA (siRNA) showed 100% and sustained serum HBsAg over an approximate 11-month period.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Expert insights. Personalized for you.
52 
Let's personalize your content